Database Solutions
Beacon Database Solutions

Access exclusive datasets of pre-clinical, clinical and commercial data for complex therapeutics.

Complete with granular proprietary ontologies for precision searching and filtering.
Modalities

ADC

Bispecific

DDR

Cell Therapy

Cancer Vaccine

Microbiome

Gene Therapy

Checkpoint

Oncolytic Viruses

RNA

Cytokine

TPD
Disease Areas

Oncology

Immune Tolerance
Services
Beacon Services

Beacon APIs enable you to integrate Beacon data into your internal systems and dashboards.

Hanson Wade Intelligence provides bespoke market research and consultancy services
APIs

Benchmarking & Pipeline Prioritization

Client Finder

Competitive Landscape

Service Alignment

Strategic Partnerships, Licensing & Acquisitions
Market Research

Hanson Wade Intelligence
Our Data
Beacon Data

Beacon data is manually curated by sector specialist analysts, to ensure unrivalled accuracy and comprehensiveness.
Our Data

Drug Data

Trial Data

Company Data

Deal Data
Resources
Beacon Resources

Our resources offer strategic insight into the drug and trial landscape of multiple therapeutic and disease areas.

ALL RESOURCES
Resources

Conference Reports

Infographics

Landscape Reviews

Market Reports

Webinars

Microbiome Drug Development Milestones

There are currently two drugs approved by the FDA for the treatment of recurrent CDI (rCDI): REBYOTA and VOWST. Our Beacon Microbiome team have explored a decades worth of data to provide an overview of the key milestones for these two Microbiome approvals. The infographic, that is now available to download, includes a timeline of trial start and end dates, trial updates, key publications and top news stories.

Download Infographic

Microbiome Drug Development Milestones Infographic

What’s covered in the infographic:

Overview of the use of FMT therapies for the prevention of CDI and CDI recurrence
Timeline of key milestones for both REBYOTA and VOWST
Predicted milestones

Download Infographic

You May Also Be Interested In…

Microbiome Landscape Review

Access Review

Microbiome Drug Development in Asia

Access Infographic

Webinar date:

Microbiome Targeting Therapeutics in Infectious Disease

Access Webinar

View All

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more